Ann: Shareholder Newsletter, page-3

Well presented Newsletter .... if they are going to do this though all I ask is they keep it regular (say) bi-monthly instead of just when they feel like it ?  A bi-monthly newsletter could perhaps provide for an ongoing Viraleze sales update ?

Not sure why India wasn't mentioned in the Quarterly yesterday though (a Market Sensitive) announcement but raised today in the Shareholder Newsletter (a non Market Sensitive) announcement .... the highlighted comments from the newsletter below seem important to me especially given the situation over there ?

Starpharma is pursuing avenues to provide rapid access to VIRALEZE™ in India, including opportunities for expedited registration and distribution in the region. The Company is also progressing regulatory activities for a number of markets, including Australia. Starpharma will make further announcements upon registration and launch of the product in other countries/regions.

https://www.worldometers.info/coronavirus/